226 related articles for article (PubMed ID: 21465528)
1. Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation.
Wang W; Liu L; Song X; Mo Y; Komma C; Bellamy HD; Zhao ZJ; Zhou GW
J Cell Biochem; 2011 Aug; 112(8):2062-71. PubMed ID: 21465528
[TBL] [Abstract][Full Text] [Related]
2. SHP-1 tyrosine phosphatase binding to c-Src kinase phosphor-dependent conformations: A comparative structural framework.
Gul M; Navid A; Fakhar M; Rashid S
PLoS One; 2023; 18(1):e0278448. PubMed ID: 36638102
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of human protein-tyrosine phosphatase SHP-1.
Yang J; Liu L; He D; Song X; Liang X; Zhao ZJ; Zhou GW
J Biol Chem; 2003 Feb; 278(8):6516-20. PubMed ID: 12482860
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the tyrosine phosphatase SHP-2.
Hof P; Pluskey S; Dhe-Paganon S; Eck MJ; Shoelson SE
Cell; 1998 Feb; 92(4):441-50. PubMed ID: 9491886
[TBL] [Abstract][Full Text] [Related]
5. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic studies on full length and the catalytic domain of the tandem SH2 domain-containing protein tyrosine phosphatase: analysis of phosphoenzyme levels and Vmax stimulatory effects of glycerol and of a phosphotyrosyl peptide ligand.
Wang J; Walsh CT
Biochemistry; 1997 Mar; 36(10):2993-9. PubMed ID: 9062130
[TBL] [Abstract][Full Text] [Related]
7. Modulation of SHP-1 phosphatase activity by monovalent and bivalent SH2 phosphopeptide ligands.
Teichmann K; Kühl T; Könnig I; Wieligmann K; Zacharias M; Imhof D
Biopolymers; 2010 Jan; 93(1):102-12. PubMed ID: 19768778
[TBL] [Abstract][Full Text] [Related]
8. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
9. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2.
Barford D; Neel BG
Structure; 1998 Mar; 6(3):249-54. PubMed ID: 9551546
[TBL] [Abstract][Full Text] [Related]
10. Kinetic comparison of the catalytic domains of SHP-1 and SHP-2.
Niu T; Liang X; Yang J; Zhao Z; Zhou GW
J Cell Biochem; 1999 Jan; 72(1):145-50. PubMed ID: 10025675
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs.
Zhao R; Zhao ZJ
J Biol Chem; 2000 Feb; 275(8):5453-9. PubMed ID: 10681522
[TBL] [Abstract][Full Text] [Related]
12. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
13. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
[TBL] [Abstract][Full Text] [Related]
14. Association of 3BP2 with SHP-1 regulates SHP-1-mediated production of TNF-α in RBL-2H3 cells.
Chihara K; Nakashima K; Takeuchi K; Sada K
Genes Cells; 2011 Dec; 16(12):1133-45. PubMed ID: 22077594
[TBL] [Abstract][Full Text] [Related]
15. Tyr66 acts as a conformational switch in the closed-to-open transition of the SHP-2 N-SH2-domain phosphotyrosine-peptide binding cleft.
Guvench O; Qu CK; MacKerell AD
BMC Struct Biol; 2007 Mar; 7():14. PubMed ID: 17378938
[TBL] [Abstract][Full Text] [Related]
16. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.
Sweeney MC; Wavreille AS; Park J; Butchar JP; Tridandapani S; Pei D
Biochemistry; 2005 Nov; 44(45):14932-47. PubMed ID: 16274240
[TBL] [Abstract][Full Text] [Related]
17. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
18. Shp-2 tyrosine phosphatase: signaling one cell or many.
Feng GS
Exp Cell Res; 1999 Nov; 253(1):47-54. PubMed ID: 10579910
[TBL] [Abstract][Full Text] [Related]
19. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2.
Jackson DE; Kupcho KR; Newman PJ
J Biol Chem; 1997 Oct; 272(40):24868-75. PubMed ID: 9312087
[TBL] [Abstract][Full Text] [Related]
20. SHP family protein tyrosine phosphatases adopt canonical active-site conformations in the apo and phosphate-bound states.
Alicea-Velazquez NL; Boggon TJ
Protein Pept Lett; 2013 Sep; 20(9):1039-48. PubMed ID: 23514039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
